PMC:7111504 / 7580-8183 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"123","span":{"begin":91,"end":100},"obj":"Species"},{"id":"124","span":{"begin":331,"end":340},"obj":"Species"},{"id":"125","span":{"begin":476,"end":485},"obj":"Species"}],"attributes":[{"id":"A123","pred":"tao:has_database_id","subj":"123","obj":"Tax:2697049"},{"id":"A124","pred":"tao:has_database_id","subj":"124","obj":"Tax:2697049"},{"id":"A125","pred":"tao:has_database_id","subj":"125","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"We could see a similar (close to identical) immunogenicity scores for a number of IEDB and 2019-nCov peptides especially for those with high immunogenicity scores ( Figure 2). While all 48 can be potential targets, of particular interest were those having higher immunogenicity score than IEDB peptides. Here, we list 22 out of 48 2019-nCoV peptides that scored higher compared to their targets that have been characterized to be immunogenic ( Table 2). In this list 15 (68%) 2019-nCov peptides have a score higher than 0.5 whereas only 11(50%) of IEDB get a score immunogenicity score greater than 0.5."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T89","span":{"begin":44,"end":58},"obj":"BV_15"},{"id":"T90","span":{"begin":91,"end":100},"obj":"SP_7"},{"id":"T91","span":{"begin":141,"end":155},"obj":"BV_15"},{"id":"T92","span":{"begin":263,"end":277},"obj":"BV_15"},{"id":"T93","span":{"begin":331,"end":340},"obj":"SP_7"},{"id":"T94","span":{"begin":430,"end":441},"obj":"CHEBI:60816;CHEBI:60816"},{"id":"T95","span":{"begin":476,"end":485},"obj":"SP_7"},{"id":"T96","span":{"begin":565,"end":579},"obj":"BV_15"},{"id":"T4440","span":{"begin":44,"end":58},"obj":"BV_15"},{"id":"T13636","span":{"begin":91,"end":100},"obj":"SP_7"},{"id":"T61633","span":{"begin":141,"end":155},"obj":"BV_15"},{"id":"T19852","span":{"begin":263,"end":277},"obj":"BV_15"},{"id":"T63857","span":{"begin":331,"end":340},"obj":"SP_7"},{"id":"T42242","span":{"begin":430,"end":441},"obj":"CHEBI:60816;CHEBI:60816"},{"id":"T74171","span":{"begin":476,"end":485},"obj":"SP_7"},{"id":"T89996","span":{"begin":565,"end":579},"obj":"BV_15"}],"text":"We could see a similar (close to identical) immunogenicity scores for a number of IEDB and 2019-nCov peptides especially for those with high immunogenicity scores ( Figure 2). While all 48 can be potential targets, of particular interest were those having higher immunogenicity score than IEDB peptides. Here, we list 22 out of 48 2019-nCoV peptides that scored higher compared to their targets that have been characterized to be immunogenic ( Table 2). In this list 15 (68%) 2019-nCov peptides have a score higher than 0.5 whereas only 11(50%) of IEDB get a score immunogenicity score greater than 0.5."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T111","span":{"begin":13,"end":14},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T112","span":{"begin":70,"end":71},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T113","span":{"begin":101,"end":109},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T114","span":{"begin":186,"end":188},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T115","span":{"begin":294,"end":302},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T116","span":{"begin":318,"end":320},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T117","span":{"begin":328,"end":330},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T118","span":{"begin":341,"end":349},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T119","span":{"begin":486,"end":494},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T120","span":{"begin":500,"end":501},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T121","span":{"begin":537,"end":539},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T122","span":{"begin":557,"end":558},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"We could see a similar (close to identical) immunogenicity scores for a number of IEDB and 2019-nCov peptides especially for those with high immunogenicity scores ( Figure 2). While all 48 can be potential targets, of particular interest were those having higher immunogenicity score than IEDB peptides. Here, we list 22 out of 48 2019-nCoV peptides that scored higher compared to their targets that have been characterized to be immunogenic ( Table 2). In this list 15 (68%) 2019-nCov peptides have a score higher than 0.5 whereas only 11(50%) of IEDB get a score immunogenicity score greater than 0.5."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T62","span":{"begin":101,"end":109},"obj":"Chemical"},{"id":"T63","span":{"begin":294,"end":302},"obj":"Chemical"},{"id":"T64","span":{"begin":341,"end":349},"obj":"Chemical"},{"id":"T65","span":{"begin":486,"end":494},"obj":"Chemical"}],"attributes":[{"id":"A62","pred":"chebi_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A63","pred":"chebi_id","subj":"T63","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A64","pred":"chebi_id","subj":"T64","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A65","pred":"chebi_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"We could see a similar (close to identical) immunogenicity scores for a number of IEDB and 2019-nCov peptides especially for those with high immunogenicity scores ( Figure 2). While all 48 can be potential targets, of particular interest were those having higher immunogenicity score than IEDB peptides. Here, we list 22 out of 48 2019-nCoV peptides that scored higher compared to their targets that have been characterized to be immunogenic ( Table 2). In this list 15 (68%) 2019-nCov peptides have a score higher than 0.5 whereas only 11(50%) of IEDB get a score immunogenicity score greater than 0.5."}

{"project":"LitCovid-sentences","denotations":[{"id":"T80","span":{"begin":0,"end":175},"obj":"Sentence"},{"id":"T81","span":{"begin":176,"end":303},"obj":"Sentence"},{"id":"T82","span":{"begin":304,"end":453},"obj":"Sentence"},{"id":"T83","span":{"begin":454,"end":603},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We could see a similar (close to identical) immunogenicity scores for a number of IEDB and 2019-nCov peptides especially for those with high immunogenicity scores ( Figure 2). While all 48 can be potential targets, of particular interest were those having higher immunogenicity score than IEDB peptides. Here, we list 22 out of 48 2019-nCoV peptides that scored higher compared to their targets that have been characterized to be immunogenic ( Table 2). In this list 15 (68%) 2019-nCov peptides have a score higher than 0.5 whereas only 11(50%) of IEDB get a score immunogenicity score greater than 0.5."}